These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8315343)

  • 1. [Helicobacter pylori infections].
    Nasu M
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):437-40. PubMed ID: 8315343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 4. [Helicobacter and peptic ulcer: history, diagnosis and therapy--when, in whom and how?].
    Beglinger C
    Schweiz Med Wochenschr; 1994 Mar; 124(10):426-8. PubMed ID: 8153602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
    Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
    Furuta T; Soya Y; Sugimoto M; Shirai N; Nakamura A; Kodaira C; Nishino M; Okuda M; Okimoto T; Murakami K; Fujioka T; Hishida A
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1810-5. PubMed ID: 17914955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori, peptic diseases and colloid bismuth].
    Loizeau E
    Rev Med Suisse Romande; 1990 Oct; 110(10):881-3. PubMed ID: 2244100
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina.
    Stege PW; Vega AE
    Int J Antimicrob Agents; 2006 Nov; 28(5):477-8. PubMed ID: 17046207
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems following antibiotic therapy for eradication of Helicobacter pylori].
    Sato R; Kubota T; Murakami K; Fujioka T
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):881-5. PubMed ID: 9648440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antimicrobial sensitivity of Helicobacter pyloriø].
    López-Brea M
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():32-5. PubMed ID: 7914433
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of the peptic ulcer patient in the Helicobacter pylori age].
    Marshall BJ
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():36-40. PubMed ID: 7914434
    [No Abstract]   [Full Text] [Related]  

  • 15. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 16. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
    Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
    Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of resistance to antimicrobial agents of H. pylori].
    Raymond J; Kalach N; Lamarque D; Burucoa C
    Arch Pediatr; 2010 Jun; 17(6):816-7. PubMed ID: 20654908
    [No Abstract]   [Full Text] [Related]  

  • 18. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barry Marshall, MD: H pylori 35 Years Later.
    Abbasi J
    JAMA; 2017 Apr; 317(14):1400-1402. PubMed ID: 28399250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peptic acid disease associated with Helicobacter pylori in children. Report of a case].
    Tovar Calderón S; Ramírez Mayans J; Casaubón Garcín P; Medina Escobedo G; Cueva Carrillo J; Mora Tiscareño MA
    Rev Gastroenterol Mex; 1992; 57(1):37-40. PubMed ID: 1621037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.